About 77,100 results
Open links in new tab
  1. Antiretroviral Therapy and HIV Drug Resistance - PAHO

    Jun 28, 2021 · Explore comprehensive information on antiretroviral therapy (ART) for HIV, including the latest guidelines, benefits, and PAHO's strategic initiatives. Learn about the …

  2. World Aids Day 2025 - PAHO/WHO | Pan American Health …

    Nov 25, 2025 · World AIDS Day 2025: Alliance for HIV Elimination in the Americas December 5, 2025 - 10:00 a.m. - 11:30 a.m. (Washington DC Time) Despite significant progress in the …

  3. Terapia Antirretroviral y Farmacorresistencia del VIH

    La terapia antirretroviral (TAR) es el tratamiento de las personas infectadas con el virus de la inmunodeficiencia humana (VIH) con fármacos anti-VIH. El tratamiento consiste en una …

  4. HIV Drug Resistance - PAHO/WHO | Pan American Health …

    Mar 15, 2023 · HIV drug resistance (HIVDR) is the ability of HIV to mutate and reproduce in the presence of antiretroviral (ARV) drugs. The consequences of drug resistance include …

  5. Scale up antiretroviral therapy: -Provide immediate ART to all HIV people diagnosed -Ensure lifelong adherence through support programs and multimonth dispensing strategies Integrate …

  6. HIV/AIDS - PAHO/WHO | Pan American Health Organization

    5 days ago · ART reduces mortality and morbidity rates among HIV-infected people, and improves their quality of life. The benefits of ART also include the prevention of HIV transmission by …

  7. Concept note: Surveillance of HIV drug resistance in adults ... - PAHO

    Jul 7, 2014 · HIV Drug Resistance emerges when HIV replicates in the presence of antiretroviral drugs. If HIV drug resistance becomes widespread, the drugs currently used to treat HIV …

  8. Paediatric Abacavir/Lamivudine/Dolutegravir (pALD) Fixed-Dose ...

    Jun 6, 2023 · Background Dolutegravir (DTG)-based HIV treatment regimens are recommended by the World Health Organization (WHO) for children living with HIV (CLHIV) who weigh at …

  9. Updated recommendations on first-line and second-line ... - PAHO

    Dec 21, 2018 · Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral …

  10. PrEP, PEP, and Key Populations - PAHO/WHO | Pan American …

    Jun 27, 2025 · PrEP is for HIV-negative adolescents or adults who are exposed to the virus through sex or injecting drug use. Current guidelines of the World Health Organization (WHO) …